Human Chorionic Gonadotropin (HCG) Market Report

Global and Region Human Chorionic Gonadotropin (HCG) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：176
  • REPORT CODE：GMM952944
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Human chorionic gonadotropin (HCG) is a female hormone produced by the placenta after implantation of the egg, which is why it can be detected in a few pregnancy tests. In addition, it can be extracted from the urine of pregnant women or produced from cultures of genetically modified cells using recombinant DNA technology.

    The major factors that fuel the growth of the market are the rising incidence of infertility issues among men and women, along with the increasing maternity age among women. In addition, the rising preference for hormonal drug therapy supplements the market growth.

    The report details the trend, potential and market size of Human Chorionic Gonadotropin (HCG) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Human Chorionic Gonadotropin (HCG)market, defines the market attractiveness level of Human Chorionic Gonadotropin (HCG) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Human Chorionic Gonadotropin (HCG) industry, describes the types of Human Chorionic Gonadotropin (HCG) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Human Chorionic Gonadotropin (HCG) market and the development prospects and opportunities of Human Chorionic Gonadotropin (HCG) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Human Chorionic Gonadotropin (HCG) market in Chapter 13.

    By Player:

    • Cigna

    • Leebio

    • Fresenius Kabi AG, LLC

    • Sanzyme

    • Ferring BV

    • Scrippslabs

    • Merck & Co, Inc

    • Bristol Myers Squibb Company

    • Kamiya Biomedical Company

    • EMD Serono, Inc

    By Type:

    • Natural Source Extraction

    • Recombinant DNA Technology

    By End-User:

    • Female Infertility Treatment

    • Oligospermic Treatment

    • Cryptorchidism Treatment

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Human Chorionic Gonadotropin (HCG) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Human Chorionic Gonadotropin (HCG) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Human Chorionic Gonadotropin (HCG) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Human Chorionic Gonadotropin (HCG) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Human Chorionic Gonadotropin (HCG) Market Analysis and Outlook to 2022

    • 7.1 Global Human Chorionic Gonadotropin (HCG) Consumption (2017-2022)

    • 7.2 United States Human Chorionic Gonadotropin (HCG) Consumption (2017-2022)

    • 7.3 Europe Human Chorionic Gonadotropin (HCG) Consumption (2017-2022)

    • 7.4 China Human Chorionic Gonadotropin (HCG) Consumption (2017-2022)

    • 7.5 Japan Human Chorionic Gonadotropin (HCG) Consumption (2017-2022)

    • 7.6 India Human Chorionic Gonadotropin (HCG) Consumption (2017-2022)

    • 7.7 South Korea Human Chorionic Gonadotropin (HCG) Consumption (2017-2022)

    8 Region and Country-wise Human Chorionic Gonadotropin (HCG) Market Analysis and Outlook to 2028

    • 8.1 Global Human Chorionic Gonadotropin (HCG) Consumption Forecast (2022-2028)

    • 8.2 United States Human Chorionic Gonadotropin (HCG) Consumption Forecast (2022-2028)

    • 8.3 Europe Human Chorionic Gonadotropin (HCG) Consumption Forecast (2022-2028)

    • 8.4 China Human Chorionic Gonadotropin (HCG) Consumption Forecast (2022-2028)

    • 8.5 Japan Human Chorionic Gonadotropin (HCG) Consumption Forecast (2022-2028)

    • 8.6 India Human Chorionic Gonadotropin (HCG) Consumption Forecast (2022-2028)

    • 8.7 South Korea Human Chorionic Gonadotropin (HCG) Consumption Forecast (2022-2028)

    9 Global Human Chorionic Gonadotropin (HCG) Market Outlook by Types and Applications to 2022

    • 9.1 Global Human Chorionic Gonadotropin (HCG) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Natural Source Extraction Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Recombinant DNA Technology Consumption and Growth Rate (2017-2022)

    • 9.2 Global Human Chorionic Gonadotropin (HCG) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Female Infertility Treatment Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Oligospermic Treatment Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Cryptorchidism Treatment Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Human Chorionic Gonadotropin (HCG) Market Outlook by Types and Applications to 2028

    • 10.1 Global Human Chorionic Gonadotropin (HCG) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Natural Source Extraction Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Human Chorionic Gonadotropin (HCG) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Female Infertility Treatment Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Oligospermic Treatment Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Cryptorchidism Treatment Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Human Chorionic Gonadotropin (HCG) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Human Chorionic Gonadotropin (HCG) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Human Chorionic Gonadotropin (HCG) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Human Chorionic Gonadotropin (HCG) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Human Chorionic Gonadotropin (HCG) Market Competitive Analysis

    • 14.1 Cigna

      • 14.1.1 Cigna Company Details

      • 14.1.2 Cigna Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Cigna Human Chorionic Gonadotropin (HCG) Product and Service

    • 14.2 Leebio

      • 14.2.1 Leebio Company Details

      • 14.2.2 Leebio Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Leebio Human Chorionic Gonadotropin (HCG) Product and Service

    • 14.3 Fresenius Kabi AG, LLC

      • 14.3.1 Fresenius Kabi AG, LLC Company Details

      • 14.3.2 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Product and Service

    • 14.4 Sanzyme

      • 14.4.1 Sanzyme Company Details

      • 14.4.2 Sanzyme Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Sanzyme Human Chorionic Gonadotropin (HCG) Product and Service

    • 14.5 Ferring BV

      • 14.5.1 Ferring BV Company Details

      • 14.5.2 Ferring BV Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Ferring BV Human Chorionic Gonadotropin (HCG) Product and Service

    • 14.6 Scrippslabs

      • 14.6.1 Scrippslabs Company Details

      • 14.6.2 Scrippslabs Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Scrippslabs Human Chorionic Gonadotropin (HCG) Product and Service

    • 14.7 Merck & Co, Inc

      • 14.7.1 Merck & Co, Inc Company Details

      • 14.7.2 Merck & Co, Inc Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Merck & Co, Inc Human Chorionic Gonadotropin (HCG) Product and Service

    • 14.8 Bristol Myers Squibb Company

      • 14.8.1 Bristol Myers Squibb Company Company Details

      • 14.8.2 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product and Service

    • 14.9 Kamiya Biomedical Company

      • 14.9.1 Kamiya Biomedical Company Company Details

      • 14.9.2 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product and Service

    • 14.10 EMD Serono, Inc

      • 14.10.1 EMD Serono, Inc Company Details

      • 14.10.2 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Human Chorionic Gonadotropin (HCG)

    • Figure Human Chorionic Gonadotropin (HCG) Picture

    • Table Global Human Chorionic Gonadotropin (HCG) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Human Chorionic Gonadotropin (HCG) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Human Chorionic Gonadotropin (HCG) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Human Chorionic Gonadotropin (HCG) Consumption by Country (2017-2022)

    • Figure United States Human Chorionic Gonadotropin (HCG) Consumption and Growth Rate (2017-2022)

    • Table Europe Human Chorionic Gonadotropin (HCG) Consumption and Growth Rate (2017-2022)

    • Figure China Human Chorionic Gonadotropin (HCG) Consumption and Growth Rate (2017-2022)

    • Figure Japan Human Chorionic Gonadotropin (HCG) Consumption and Growth Rate (2017-2022)

    • Figure India Human Chorionic Gonadotropin (HCG) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Human Chorionic Gonadotropin (HCG) Consumption and Growth Rate (2017-2022)

    • Figure Global Human Chorionic Gonadotropin (HCG) Consumption Forecast by Country (2022-2028)

    • Figure United States Human Chorionic Gonadotropin (HCG) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Human Chorionic Gonadotropin (HCG) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Human Chorionic Gonadotropin (HCG) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Human Chorionic Gonadotropin (HCG) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Human Chorionic Gonadotropin (HCG) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Human Chorionic Gonadotropin (HCG) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Natural Source Extraction Consumption and Growth Rate (2017-2022)

    • Figure Global Recombinant DNA Technology Consumption and Growth Rate (2017-2022)

    • Figure Global Female Infertility Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Oligospermic Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Cryptorchidism Treatment Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Natural Source Extraction Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Recombinant DNA Technology Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Female Infertility Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oligospermic Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cryptorchidism Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Human Chorionic Gonadotropin (HCG) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Human Chorionic Gonadotropin (HCG) Export by Region (Top 5 Countries) (2017-2028)

    • Table Cigna (Foundation Year, Company Profile and etc.)

    • Table Cigna Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cigna Human Chorionic Gonadotropin (HCG) Product and Service

    • Table Leebio (Foundation Year, Company Profile and etc.)

    • Table Leebio Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Leebio Human Chorionic Gonadotropin (HCG) Product and Service

    • Table Fresenius Kabi AG, LLC (Foundation Year, Company Profile and etc.)

    • Table Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fresenius Kabi AG, LLC Human Chorionic Gonadotropin (HCG) Product and Service

    • Table Sanzyme (Foundation Year, Company Profile and etc.)

    • Table Sanzyme Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanzyme Human Chorionic Gonadotropin (HCG) Product and Service

    • Table Ferring BV (Foundation Year, Company Profile and etc.)

    • Table Ferring BV Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ferring BV Human Chorionic Gonadotropin (HCG) Product and Service

    • Table Scrippslabs (Foundation Year, Company Profile and etc.)

    • Table Scrippslabs Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Scrippslabs Human Chorionic Gonadotropin (HCG) Product and Service

    • Table Merck & Co, Inc (Foundation Year, Company Profile and etc.)

    • Table Merck & Co, Inc Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co, Inc Human Chorionic Gonadotropin (HCG) Product and Service

    • Table Bristol Myers Squibb Company (Foundation Year, Company Profile and etc.)

    • Table Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol Myers Squibb Company Human Chorionic Gonadotropin (HCG) Product and Service

    • Table Kamiya Biomedical Company (Foundation Year, Company Profile and etc.)

    • Table Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kamiya Biomedical Company Human Chorionic Gonadotropin (HCG) Product and Service

    • Table EMD Serono, Inc (Foundation Year, Company Profile and etc.)

    • Table EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Sales, Price, Value and Gross Profit (2017-2022)

    • Table EMD Serono, Inc Human Chorionic Gonadotropin (HCG) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US